281 related articles for article (PubMed ID: 17196388)
21. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
Xu Y; Chen L; Li C
J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
[TBL] [Abstract][Full Text] [Related]
22. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
Kurnatowski P; Makieło L; Horwatt-Bozyczko E
Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440
[TBL] [Abstract][Full Text] [Related]
23. Fluconazole resistance in Candida albicans: a review of mechanisms.
Casalinuovo IA; Di Francesco P; Garaci E
Eur Rev Med Pharmacol Sci; 2004; 8(2):69-77. PubMed ID: 15267120
[TBL] [Abstract][Full Text] [Related]
24. Acetylenic acids inhibiting azole-resistant Candida albicans from Pentagonia gigantifolia.
Li XC; Jacob MR; ElSohly HN; Nagle DG; Smillie TJ; Walker LA; Clark AM
J Nat Prod; 2003 Aug; 66(8):1132-5. PubMed ID: 12932143
[TBL] [Abstract][Full Text] [Related]
25. Effect of plant oils on Candida albicans.
Agarwal V; Lal P; Pruthi V
J Microbiol Immunol Infect; 2010 Oct; 43(5):447-51. PubMed ID: 21075713
[TBL] [Abstract][Full Text] [Related]
26. The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility.
Yan L; Li M; Cao Y; Gao P; Cao Y; Wang Y; Jiang Y
J Antimicrob Chemother; 2009 Oct; 64(4):764-73. PubMed ID: 19656781
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH
Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851
[TBL] [Abstract][Full Text] [Related]
28. Potential of plant oils as inhibitors of Candida albicans growth.
Devkatte AN; Zore GB; Karuppayil SM
FEMS Yeast Res; 2005 Jun; 5(9):867-73. PubMed ID: 15925315
[TBL] [Abstract][Full Text] [Related]
29. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationship studies of ultra-short peptides with potent activities against fluconazole-resistant Candida albicans.
Ng SMS; Yap JM; Lau QY; Ng FM; Ong EHQ; Barkham T; Teo JWP; Alfatah M; Kong KW; Hoon S; Arumugam P; Hill J; Brian Chia CS
Eur J Med Chem; 2018 Apr; 150():479-490. PubMed ID: 29549835
[TBL] [Abstract][Full Text] [Related]
31. Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery.
Liu S; Hou Y; Chen X; Gao Y; Li H; Sun S
Int J Antimicrob Agents; 2014 May; 43(5):395-402. PubMed ID: 24503221
[TBL] [Abstract][Full Text] [Related]
32. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
33. The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans.
Li X; Cai Q; Mei H; Zhou X; Shen Y; Li D; Liu W
J Antimicrob Chemother; 2015 Jul; 70(7):1993-2003. PubMed ID: 25825380
[TBL] [Abstract][Full Text] [Related]
34. Subinhibitory concentrations of fluconazole increase the intracellular sodium content in both fluconazole-resistant and -sensitive Candida albicans strains.
Kolecka A; Krauke Y; Bujdakova H; Sychrova H
Can J Microbiol; 2009 May; 55(5):605-10. PubMed ID: 19483789
[TBL] [Abstract][Full Text] [Related]
35. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
Shahid Z; Sobel JD
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794
[TBL] [Abstract][Full Text] [Related]
36. [Antibacterial and antifungal compounds. VIII. Synthesis and antifungal activity of pyrrol derivatives similar to trichostatin A].
Corelli F; Massa S; Stefancich G; Mai A; Artico M; Panico S; Simonetti N
Farmaco Sci; 1987 Dec; 42(12):893-903. PubMed ID: 3329612
[TBL] [Abstract][Full Text] [Related]
37. Candida albicans switch phenotypes display differential levels of fitness.
Vargas K; Srikantha R; Holke A; Sifri T; Morris R; Joly S
Med Sci Monit; 2004 Jul; 10(7):BR198-206. PubMed ID: 15232493
[TBL] [Abstract][Full Text] [Related]
38. The synthesis and synergistic antifungal effects of chalcones against drug resistant Candida albicans.
Wang YH; Dong HH; Zhao F; Wang J; Yan F; Jiang YY; Jin YS
Bioorg Med Chem Lett; 2016 Jul; 26(13):3098-3102. PubMed ID: 27210436
[TBL] [Abstract][Full Text] [Related]
39. Structural optimization of berberine as a synergist to restore antifungal activity of fluconazole against drug-resistant Candida albicans.
Liu H; Wang L; Li Y; Liu J; An M; Zhu S; Cao Y; Jiang Z; Zhao M; Cai Z; Dai L; Ni T; Liu W; Chen S; Wei C; Zang C; Tian S; Yang J; Wu C; Zhang D; Liu H; Jiang Y
ChemMedChem; 2014 Jan; 9(1):207-16. PubMed ID: 24376206
[TBL] [Abstract][Full Text] [Related]
40. Carboxylic acid and phosphate ester derivatives of fluconazole: synthesis and antifungal activities.
Nam NH; Sardari S; Selecky M; Parang K
Bioorg Med Chem; 2004 Dec; 12(23):6255-69. PubMed ID: 15519168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
